Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway

ABSTRACT:

SUBMITTER: Lin J 

PROVIDER: S-EPMC12343881 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature